Changes in the Expression of Many Ets Family Transcription Factors and of Potential Target Genes in Normal Mammary Tissue and Tumors
Open accessThe DOI matches its Crossref record; 74 of the 75 references it cites were found in a registry or an index.
Abstract
Interfering with Ets transcription factor function reverses multiple aspects of the transformed phenotype of mouse or human tumor cells. However, the unknown number of individual Ets factors expressed in any cellular context and the similar DNA binding specificities of Ets family members complicates the identification of those that mediate transformation. By utilizing quantitative PCR assays for 25 mouse Ets factors, we analyzed the expression of essentially the entire Ets family in normal mammary tissue, mammary-related cell lines, and mammary tumors. In normal mammary tissue, 24 Ets factors were expressed. Even clonal derived cell lines expressed 14-20 Ets members. The most abundant Ets factor mRNAs measured in normal mammary tissue were Elk4, Elf1, and Ets2. Subtractive analysis of mammary tissue identified which Ets factors were predominantly expressed in the myeloid/lymphoid or epithelial cell compartments. Comparison of Ets factor expression in normal mammary tissue and mammary tumors identified significantly elevated expression of Pse/PDEF, Ese2/Elf5, Ese3/Ehf, TEL/Etv6, and Elf2/NERF in mammary tumors and confirmed previously reported alterations in expression of Ese1/Elf3 and the PEA3 subfamily. Expression of 13 Ets target genes, implicated in various aspects of tumor progression, was also analyzed. Altered expression of particular Ets target genes was significantly correlated with particular Ets factors (e.g. maspin and Ese2), suggesting specific in vivo regulatory roles. Together, this comprehensive analysis revealed unexpectedly diverse Ets family gene expression, characterized novel Ets factor changes in mammary tumors, and implicated specific Ets factors in the regulation of multiple genes involved in mammary tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In any particular cell type, 14 to 25 family members are coexpressed.”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Half of the family members are ubiquitously expressed in all cell types tested.”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [35]
Experimental — accuracy not yet measuredIn the citing paper
“In spite of the biological and biochemical evidence that different ETS proteins can execute diverse roles, an extensive overlap in the expression of various family members is found in many human tissues.”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [35]
In the citing paper
“Expression profiles in transformed cell lines show strong similarity to those in matching normal tissues, although exceptions are worth noting.”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
Manipulating the mouse embryo: A laboratory manual
Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460
Manipulating the mouse embryo: A laboratory manual
Johnson, M. (1986) · Trends in Genetics · doi:10.1016/0168-9525(86)90275-1 · Cited by 2,245
Guy, C. T., Cardiff, R. D., & Muller, W. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.954 · Cited by 1,631
Self-citationGuy, C. T., Webster, M. A., Schaller, M., Parsons, T. J., Cardiff, R. D., & Muller, W. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10578 · Cited by 1,193
Self-citationThe ETS-domain transcription factor family
Sharrocks, A. D. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099076 · Cited by 1,086
Transforming p21 Mutants and c-Ets-2 Activate the Cyclin D1 Promoter through Distinguishable Regions
Albanese, C., Johnson, J., Watanabe, G., Eklund, N., Vu, D., Arnold, A., & Pestell, R. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23589 · Cited by 803
Molecular biology of the Ets family of transcription factors
Oikawa, T., & Yamada, T. (2003) · Gene · doi:10.1016/s0378-1119(02)01156-3 · Cited by 688
Ball, R. K., Friis, R. R., Schoenenberger, C. A., Doppler, W., & Groner, B. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03048.x · Cited by 504
Zhong, H., & Simons, J. W. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0815 · Cited by 470
Research works printed but not linked: 15
- 5. Dittmer, J. ∙ Nordheim, A. Biochim. Biophys. Acta. 1998; 1377:F1-F11 PubMed Google Scholar
- 8. Langer, S.J. ∙ Bortner, D.M. ∙ Roussel, M.F. ... Mol. Cell. Biol. 1992; 12:5355-5362 Crossref Scopus (147) PubMed Google Scholar
- 11. de Nigris, F. ∙ Mega, T. ∙ Berger, N. ... Cancer Res. 2001; 61:2267-2275 PubMed Google Scholar
- 12. Sapi, E. ∙ Flick, M.B. ∙ Rodov, S. ... Cancer Res. 1998; 58:1027-1033 PubMed Google Scholar
- 17. Neznanov, N. ∙ Man, A.K. ∙ Yamamoto, H. ... Cancer Res. 1999; 59:4242-4246 PubMed Google Scholar
- 18. Trimble, M.S. ∙ Xin, J.H. ∙ Guy, C.T. ... Oncogene. 1993; 8:3037-3042 PubMed Google Scholar
- 22. Andrechek, E.R. ∙ Laing, M.A. ∙ Girgis-Gabardo, A.A. ... Cancer Res. 2003; 63:4920-4926 PubMed Google Scholar
- 24. Ghadersohi, A. ∙ Sood, A.K. Clin. Cancer Res. 2001; 7:2731-2738 PubMed Google Scholar
- 27. Boyd, K.E. ∙ Farnham, P.J. Proc. Soc. Exp. Biol. Med. 1999; 222:9-28 Crossref Scopus (36) PubMed Google Scholar
- 36. Guy, C.T. ∙ Cardiff, R.D. ∙ Muller, W.J. Mol. Cell. Biol. 1992; 12:954-961 Crossref Scopus (1346) PubMed Google Scholar
- 41. Rozen, S. ∙ Skaletsky, H.J. Krawetz, S. ∙ Misener, S. (Editors) Bioinformatics Methods and Protocols: Methods in Molecular Biology Humana Press, Totowa, NJ, 2000; 365-386 Google Scholar
- 56. Chen, J.H. ∙ Vercamer, C. ∙ Li, Z. ... Oncogene. 1996; 13:1667-1675 PubMed Google Scholar
- 57. Zhang, M. ∙ Maass, N. ∙ Magit, D. ... Cell Growth Differ. 1997; 8:179-186 PubMed Google Scholar
- 64. Feldman, R.J. ∙ Sementchenko, V.I. ∙ Gayed, M. ... Cancer Res. 2003; 63:4626-4631 PubMed Google Scholar
- 70. Nozawa, M. ∙ Yomogida, K. ∙ Kanno, N. ... Cancer Res. 2000; 60:1348-1352 PubMed Google Scholar
Cited by
Items 101–132 of 132
Yaniw, D., & Hu, J. (2005) · Cell Research · doi:10.1038/sj.cr.7290310 · Cited by 9
Wei, Y., Puzhko, S., Wabitsch, M., & Goodyer, C. G. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0190 · Cited by 13
“Ets members are characterized by their highly conserved DNA binding (ETS) domain by which they recognize a core DNA motif, GGA(A/T) (20, 21).”
BackgroundQiu, J., Ma, L., Wang, T., Chen, J., Wang, D., Guo, Y., Li, Y., Ma, X., Chen, G., Luo, Y., et al. (2023) · Clinical & Translational Oncology · doi:10.1007/s12094-023-03083-y · Cited by 8
Chen, Y., Zou, H., Yang, L., Li, Y., Wang, L., Yan, H., & Yang, J.-L. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.5.2385 · Cited by 7
“ER81 mRNA is increased in murine cell lines and tumors that overexpress HER2/Neu (Shepherd et al., 2001; Galang et al., 2004) and is expressed in human breast tumor specimens, including some human breast tumor cell lines such as MAD-MB-231, MAD-MB-436, MAD-MB-330, BT-549, and BT-20 (Baert et al.”
BackgroundELF5, normal mammary development and the heterogeneous phenotypes of breast cancer
Gallego‐Ortega, D., Oakes, S. R., Lee, H. J., Blyth, C., & Ormandy, C. J. (2013) · Breast Cancer Management · doi:10.2217/bmt.13.50 · Cited by 9
The Role of Ets Transcription Factors in Mediating Cellular Transformation
Foos, G., & Hauser, C. A. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18932-6_8 · Cited by 6
“Our recent analysis of expression of the entire Ets family in mouse mammary tumor development found that expression of the mRNAs of nine different Ets factors was significantly elevated in mammary tumors as compared with normal mammary tissue (Galang et al. 2004).”
BackgroundSelf-citationEmerging Role of miR-320a in Lung Cancer: A Comprehensive Review
Mohanta, A., Kumar, R. R., Singh, R. K., Mandal, S., Yadav, R., Khatkar, R., Sharma, U., Uttam, V., Rana, M. K., Rana, A. P. S., et al. (2023) · Biomarkers in Medicine · doi:10.2217/bmm-2023-0215 · Cited by 5
ELF5 gene promotes milk lipid synthesis in goat mammary epithelial cells by transcriptomic analysis
Ma, C., Guo, Y., Tu, T., Cui, S., Zhong, J., Zhang, Y., Song, N., & Liu, H. (2025) · Genomics · doi:10.1016/j.ygeno.2025.111023 · Cited by 4
Hou, J., An, X., Wang, J. G., Song, Y., & Cao, B. (2014) · Small Ruminant Research · doi:10.1016/j.smallrumres.2014.06.003 · Cited by 4
SPDEF promotes the classical subtype of pancreatic ductal adenocarcinomaPreprint
Tonelli, C., Yordanov, G. N., Yuan, H., Deschênes, A., Klingbeil, O., Ting, H.-C., Brosnan, E., Doshi, A., Park, Y., Vakoc, C. R., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.18.484951 · Cited by 5
“In addition, SPDEF was shown to be overexpressed in breast cancer compared to normal tissue and act as a survival factor in ER-positive breast cancer (43-46).”
BackgroundThe Role of Pea3 Transcription Factor Subfamily in the Nervous System
Kandemir, B., & Kurnaz, I. A. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04432-w · Cited by 4
“…family members have been extensively studied with respect to their roles in cancer progression and metastasis; in mammary tumors, all members of the Pea3 sub-family were found to have high levels of expression, and these ETS proteins were reported to enhance cell invasion in prostate tumors [8–10].”
Lu, J. L., Zhang, Q., Mo, L., Chen, W., & Mao, L. (2023) · Oncology Letters · doi:10.3892/ol.2023.13981 · Cited by 3
“Abnormal expression of ELFs has been identified in various malignant tumors, influencing their biological processes (28); however, the regulatory mechanisms and clinical significance of certain ELFs in ccRCC remain unclear.”
Lyu, Z., Ma, M., Xu, Y., Wang, X., Zhu, Y., Ren, W., & Li, T. (2020) · International Journal of Clinical Oncology · doi:10.1007/s10147-020-01675-0 · Cited by 3
Wanschitz, F., Stein, E., Sutter, W., Kneidinger, D., Smolik, K., Watzinger, F., & Turhani, D. (2007) · Cells Tissues Organs · doi:10.1159/000107556 · Cited by 3
“They are reported to not only act as master regulators in the development and maturation of bone tissue in vivo [Vary et al., 2000] but also to act as critical mediators of cellular transformation and tumor formation [Bartel et al., 2000; Galang et al., 2004].”
BackgroundEpigenetic modifications of prostate-derived Ets transcription factor in breast cancer cells
Sabherwal, Y., Mahajan, N., & Zhang, M. (2013) · Oncology Reports · doi:10.3892/or.2013.2661 · Cited by 3
“The role of PDEF in normal growth and development as well as in disease states such as cancer is well established (6-8,10).”
BackgroundGABPβ2 expression during osteogenic differentiation from human osteoblast-like Saos-2 cells
Xu, X., Xiong, J., Wang, T., Zheng, M., Wu, P., Wang, X., Jiang, H., Yi, B., Lang, B., & Li, W. (2014) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.2014.0026 · Cited by 3
“The ETS family regulates a variety of physiological and pathological processes in many tissues such as development, cell proliferation, differentiation, apoptosis, migration, invasion and metastasis [5–8].”
BackgroundESE-1 in Early Development: Approaches for the Future
Lee, C. M., Wu, J., Xia, Y., & Hu, J. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00073 · Cited by 3
“Notably, Ets factors are expressed temporally during differentiation, showing sharp transitions in expression that correlate with critical commitment (Anderson et al., 1999) or growth events (Bhat et al., 1987), and distinct pattern of coexpression during tumorigenesis (Galang et al., 2004).”
BackgroundRole of SIRT7 in Prostate Cancer Progression: New Insight Into Potential Therapeutic Target
Zhang, J., Liu, C., Luo, W., & Sun, B. (2025) · Cancer Medicine · doi:10.1002/cam4.70786 · Cited by 3
Sirtuins in the biology of aging
Wątroba, M., & Szukiewicz, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-814118-2.00002-1 · Cited by 2
Molecular Dynamics and Structural Studies of the Ets Domain-DNA Complexes
Caceres, R. A., Nunes, C. P., de Azevedo, W. F., Basso, L. A., & Santos, D. S. (2007) · Current Bioinformatics · doi:10.2174/157489307781662141 · Cited by 1
Gutierrez‐Hartmann, A. (2007) · doi:10.21236/ada470141
Assinatura de mRNA entre adenoma e adenocarcinoma colorretal
Fonseca, A. S. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2014.tde-18122014-095654
ETS2 (v-ets erythroblastosis virus E26 oncogene homolog 2 (avian))
Buggy, Y., & Duffy, M. J. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/44487
“Increased Ets2 expression has been observed in breast (Buggy et al., 2006; Galang et al., 2004), prostate (Foos et al., 2000; Turner et al., 2007b), esophageal (Li et al., 2003) and hepatocellular (Liao et al., 1996) carcinomas.”
BackgroundASSOCIATION OF KALLIKREIN 5-OVEREXPRESSION WITH INVASIVENESS OF URINARY BLADDER CARCINOMA CELLS
Shinoda, Y., Mizutani, Y., Miki, T., & Inazawa, J. (2008) · The Journal of Urology · doi:10.1016/s0022-5347(08)60770-3
Mesquita, B. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/mh1t-w438
Functional analysis of epithelium-specific Ets transcription factor-1 in inflammation
Lee, C. M. (2016) · TSpace (University of Toronto)
Codon Bias of the DDR1 Gene and Transcription Factor EHF in Multiple Species
Zhang, Z., Li, W., Wang, Z., Ma, S., Zheng, F., Liu, H., Zhang, X., Ding, Y., Yin, Z., & Zheng, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910696
“A notable increase in EHF has been observed by using qPCR in a mouse model of transplanted breast cancer [24].”
BackgroundIdentification et caractérisation de nouveaux partenaires du facteur de transcription ERM
Verreman, K. (2009) · theses.fr (ABES) · doi:10.70675/bf47548ezef04z448az86a3zbfc948ca93fe
“En effet, diverses expériences ont mis en évidence que le facteur Pea3 inhibe in vitro comme in vivo la croissance des cellules cancéreuses Introduction 42 Cancer Facteur Observations Références Surexpression PEA3 Induction du phénotype invasif (Kaya et al., 1996) Sous-expression Diminution du caractère invasif des ce…”
BackgroundInfluentialLadam, F. (2010) · theses.fr (ABES) · doi:10.70675/e175f6dbz92dez451cza5a0z5ba11dc8c915
Metadata
- Authors
- Galang, C. K., Muller, W. J., Foos, G., Oshima, R. G., & Hauser, C. A.
- Affiliations
- Sanford Burnham Prebys Medical Discovery Institute (US)
- McGill University (CA)
- Corresponding author
- Hauser, Craig A.
- ORCID
- Muller, William J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-03
- Volume
- 279
- Issue
- 12
- Pages
- 11281-11292
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2087260415
- Cited by
- 132
- References
- 74
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 4 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 1 · 2017: 5 · 2016: 4 · 2015: 5 · 2014: 7 · 2013: 10 · 2012: 7
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6057 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- TSpace (University of Toronto) (submittedVersion)
- Funders
- National Institutes of Health (5r01ca063130-07)
- National Cancer Institute (R01CA074547, CA30199, CA74547, CA63130, P30CA030199)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- ETS transcription factors, mammary tumors, mammary gland, gene expression profiling, maspin, mammary tumor progression
- MeSH terms
- Animals, Cell Line, DNA-Binding Proteins, Gene Expression Regulation, Mammary Glands, Animal, Mammary Neoplasms, Experimental, Transcription Factors, Polymerase Chain Reaction, DNA, Complementary, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.